The rising incidences of medical conditions which require surgeries are estimated to drive the market demand.
Market Size – USD 56.9 million in 2018, Market Growth - CAGR of 8.1%, Market Trends – Favorable regulatory norms
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- The global Anesthesia CO2 Absorbent market is expected to reach USD 106.9 Million by 2026, according to a new report by Reports and Data. CO2 absorbents are used to absorb the exhaled gases, which mostly comprises of CO2, during the administration of anesthesia.
The increasing occurrence of accidents and chronic ailments coupled with the growth of the geriatric population are the drivers of the market demand in the forecast period. Surging incidences of surgical procedures are anticipated to fuel the growth of the market. Additionally, governing institutes including CDC, CEA and Anesthesia Patient Safety have enforced guidelines and safety parameters, which in turn, would support the growth of the market in the future.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1365
A surge in the number of people suffering from ailments which comprise neurological conditions, cardiac arrest, respiratory disorders, and diabetes has led to an escalation in the number of surgical procedures being performed for the treatment, would have a positive impact on market growth in the upcoming years. As per the World Health Organization, approximately 65 million people suffer from the chronic obstructive pulmonary disease (COPD) and 3 million people die from it every year and it is the third most leading cause behind the global death.
The degradation of inhaled anesthetics to carbon monoxide, which may produce carboxyhemoglobin concentrations above 30% due to the use of CO2 absorbents containing strong bases (NaOH and KOH) may create hindrances in the growth of the market in the forecast period.
Further key findings from the report suggest
- Medisorb dominated the market with around 30% of the market share in 2018 and is estimated to have a growth rate of 8.2% in the forecast period. The next product to follow is Soda Lime with an expected CAGR of 7.8% during the forecast period.
- The traditional Anesthetic CO2, i.e., absorbents containing sodium or potassium hydroxide held the largest market share in 2018.
- In terms of end user, hospitals occupied to the largest market share in 2018 attributing to several surgeries that are being performed in hospitals.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/anesthesia-co2-absorbent-market
- North America contributed to the largest market share in 2018 with around 40% of the market share and is projected to witness a growth rate of 7.7% in the forecast period. The market dominance of the region is due to the escalation in the number of surgeries being performed and favorable government regulations and endeavors of healthcare agencies to promote medical tourism.
- Key participants include GE Healthcare, Drager Medical GmbH, Armstrong Medical, Smiths Medical, CareFusion, Allied Healthcare, Micropore, Intersurgical, Molecular Products Group, SCL International, and Thomasnet among others.
- In December 2019, Molecular Products Group, a significant player in the market and a portfolio company of Arlington Capital Partners, announced that it has acquired SODASORB® business from a wholly owned subsidiary of Henkel AG & Co. KGaA.
- The SODASORB® product range comprises carbon dioxide absorbents which have a global presence in the healthcare and safety industries. SODASORB® products assist to safely and efficiently remove carbon dioxide from anesthesia systems, diving re-breathers, saturation diving chambers, and industrial safety equipment.
Order Now: https://www.reportsanddata.com/checkout-form/1365
Segments covered in the report:
For the purpose of this report, Reports and Data have segmented global anesthetic CO2 absorbent market on the basis of product type, type, end-user, and region:
Product Type Outlook (Revenue, USD Million; 2016-2026)
- Soda Lime
- Medisorb
- Dragersorb
- Amsorb
- Litholyme
- Others
Type Outlook (Revenue, USD Million; 2016-2026)
- Traditional
- Premium
Form Outlook (Revenue, USD Million; 2016-2026)
- Granular Form
- Powered Form (Bounded by Polymer)
End-user Outlook (Revenue, USD Million; 2016-2026)
- Hospitals
- Clinics
Regional Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2018-2026)
- North America
- U.S.
- Europe
- UK
- France
- Asia Pacific
- China
- India
- Japan
- MEA
- Latin America
- Brazil
Browse more reports of Pharmaceutical category at: https://www.reportsanddata.com/report/category/medical-devices
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com